$26.18
Price
$5.3B
Market Cap
—
P/E Ratio
-8.7
Forward P/E
$-2.82
EPS (TTM)
—
Dividend Yield
$522M
Cash
$98000
Total Debt
201M
Shares Out
$12.72
$27.80
52-Week Range
Institutional Ownership of IMMUNOVANT INC
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for IMMUNOVANT INC
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2025-Q2 | |||||
| SELL | EXIT | — | — | $15.15 | |
| 2025-Q1 | |||||
| SELL | -20.8% | 1.1M | $19M | $20.41 | |
| 2024-Q4 | |||||
| SELL | -39.4% | 1.4M | $35M | $28.89 | |
| 2024-Q2 | |||||
| BUY | +28.3% | 2.3M | $61M | $28.61 | |
| 2024-Q1 | |||||
| BUY | NEW | 1.8M | $58M | $36.61 | |
Insider Trading for IMMUNOVANT INC
No Insider Transactions
No Form 4 filings found for this stock in the last 2 years.